Press Release: Magnera Reports Second Quarter Results -- Provides Updated Outlook

Dow Jones
07 May

Magnera Reports Second Quarter Results -- Provides Updated Outlook

Second Quarter Highlights

   -- GAAP: Net sales of $824 million, Operating income of $4 million 
 
   -- Non-GAAP: Adjusted EBITDA of $89 million, Post-merger adjusted free cash 
      flow $42 million 
 
   -- Reaffirming post-merger adjusted free cash flow range & lowering full 
      year comparable Adjusted EBITDA range 

CHARLOTTE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- Magnera $(MAGN)$, a global leader in specialty materials for the consumer products and personal care markets, today reported financial results for its fiscal 2025 second quarter ended March 29, 2025. Curt Begle, Magnera's CEO, commented: "This quarter underscores the resilience of our business as we navigate ongoing global economic uncertainty. Our team has transitioned from stabilizing the business through a disciplined integration plan to actively executing on identified optimization opportunities. As anticipated, our distinctive value proposition--anchored by our global market presence, broad product portfolio, and innovation capabilities--continues to drive organic growth in attractive end markets as we support our customers' evolving product requirements.

In the face of uncertainties related to tariff driven demand concerns, we remain laser focused on executing our strategic priorities of integration, synergy realization, and profitable long-term growth. Our portfolio is primarily made up of products that people use every day, however we are prepared to take the appropriate operational and cost measures that align with short-term market realities. Our commitment to earnings and free cash flow stability will ultimately increase long-term shareholder value."

Key Financials

 
                    March Quarter     March YTD 
GAAP results        2025     2024    2025    2024 
                            ------          ------ 
Net sales             $824    $558  $1,526  $1,077 
Operating income         4      21    (18)       9 
                   -------  ------  ------  ------ 
 
 
               March 
              Quarter      Reported    Comparable(1)     March YTD      Reported    Comparable(1) 
Adjusted 
non-GAAP 
results     2025   2024    <DELTA>%      <DELTA>%       2025    2024    <DELTA>%      <DELTA>% 
Net sales   $824    $558   48%          (4%)           $1,526  $1,077   42%          (3%) 
Adjusted 
 EBITDA(1)    89      76   17%          (8%)              173     142   22%          (2%) 
 
 

(1) Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable change % normalizes the impacts of foreign currency and the recent merger with GLT. Further details related to non-GAAP measures and reconciliations can be found under our "Reconciliation of Non-GAAP Financial Measures and Estimates" section or in reconciliation tables in this release. Dollars in millions

Consolidated Overview

The net sales increase of 48% included revenue from the Glatfelter merger of $311 million partially offset by a $26 million unfavorable impact from foreign currency changes, decreased selling prices of $14 million and a 1% decline in volume.

The adjusted EBITDA increase of 17% included a contribution from the Glatfelter merger of $18 million partially offset by a $3 million unfavorable impact from foreign currency changes and unfavorable impact from price/cost spread of $3 million. The contributed Glatfelter EBITDA represents a $6 million decline compared to prior year primarily as the result of higher energy costs in Europe.

Americas

The net sales increase in the Americas segment included revenue from the Glatfelter merger of $124 million partially offset by a $15 million unfavorable impact from foreign currency changes and decreased selling prices of $12 million.

The adjusted EBITDA increase included a contribution from the Glatfelter merger of $10 million partially offset by unfavorable impact from price cost spread of $3 million and a $2 million unfavorable impact from foreign currency changes in our South America businesses.

Rest of World

The net sales increase in the Rest of World segment included revenue from the Glatfelter merger of $187 million partially offset by a $11 million unfavorable impact from foreign currency changes and a 3% volume decline.

The adjusted EBITDA increase included a contribution from the Glatfelter merger of $8 million which was down $6 million compared to prior year primarily as the result of higher energy costs in Europe.

Free Cash Flow and Net Debt

Magnera is committed to strengthening our credit metrics by paying down debt in the near term.

 
(in millions)                                March Quarter    March YTD 
-------------------------------------------  --------------  ----------- 
Cash flow from operating activities               $65           $7 
Pre-merger cash flow from operating 
 activities                                               -         90 
Additions to property, plant and equipment, 
 net                                                   (23)       (39) 
-------------------------------------------  --------------  --------- 
Post-merger adjusted free cash flow(1)            $42           $58 
(1) Further details related to non-GAAP measures and 
 reconciliations can be found under our "Reconciliation 
 of Non-GAAP Financial Measures and Estimates" section 
 or in reconciliation tables in this release. 
 
(in millions)                                March 29, 2025 
Term Loan                                         $783 
4.75% First Priority Senior Secured Notes               500 
7.25% First Priority Senior Secured Notes               800 
Debt discount, deferred fees and other 
 (net)                                                 (85) 
-------------------------------------------  -------------- 
Total debt                                       $1,998 
-------------------------------------------  -------------- 
Cash and cash equivalents                               282 
-------------------------------------------  -------------- 
Total net debt                                   $1,716 
Leverage                                          3.9x 
 
 

Fiscal Year 2025 Guidance

   -- Full year comparable adjusted EBITDA of $360 - $380 million 
   -- Post-merger adjusted free cash flow of $75 - $95 million 

Investor Conference Call

The Company will host a conference call today, May 7, 2025, at 10:00 a.m. U.S. Eastern Time to discuss our March 2025 quarter results. The webcast can be accessed here. A replay of the webcast will be available via the same link on our website after the completion of the call.

By Telephone

Participants may register for the call here now or any time up to and during the time of the call and will immediately receive the dial-in number and a unique pin to access the call. While you may register at any time up to and during the time of the call, you are encouraged to join the call 15 minutes prior to the start of the event.

About Magnera

Magnera Corporation (NYSE: MAGN) serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. Operating across 46 global facilities, Magnera is supported by over 9,000 employees.

Magnera's purpose is to better the world with new possibilities made real. For more than 160 years, the company has delivered the material solutions their partners need to thrive. Through economic upheaval, global pandemics and changing end-user needs, we have consistently found ways to solve problems and exceed expectations. The distinct scale and comprehensive portfolio of products brings customers more materials and choices. Magnera builds personal partnerships that withstand an ever-changing world.

Visit magnera.com for more information and follow @MagneraCorporation on social platforms.

Non-GAAP Financial Measures and Estimates

This press release includes non-GAAP financial measures including, but not limited to, Adjusted EBITDA, free cash flow, and comparable basis net sales and adjusted EBITDA. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in the United States of America (GAAP) is set forth at the end of this press release. Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow are not provided because such information is not available without unreasonable effort due to high variability, complexity, and low visibility with respect to certain items, including debt refinancing activity or other non-comparable items. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with U.S. GAAP.

Forward Looking Statements

Information included or incorporated by reference in Magnera Corporation's filings with the U.S. Securities and Exchange Commission (the "SEC") and press releases or other public statements contains or may contain "forward-looking" statements within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such "forward-looking" statements include, but are not limited to, statements with respect to our financial condition, results of operations and business, our expectations or beliefs concerning future events, statements about the benefits of the transaction between Glatfelter Corporation and Berry Global Group, Inc., including future financial and operating results, the combined company's plans, objectives, expectations and intentions, and other statements that are not historical facts. These statements contain words such as "believes," "expects," "may," "will," "should," "would," "could," "seeks," "approximately," "intends," "plans," "estimates," "projects," "outlook,"

"anticipates" or "looking forward" or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management of Magnera and are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. These risks and other risk factors are detailed from time to time in Magnera's reports filed with the Securities and Exchange Commission (the "SEC"), including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, including our Form 8-K/A filed on January 31, 2025, and other documents filed with the SEC. These risk factors may not contain all of the material factors that are important to you. New factors may emerge from time to time, and it is not possible to either predict new factors or assess the potential effect of any such new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available as of the date hereof. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Consolidated and Combined Statements of Income (Unaudited)

 
                  Quarterly Period       Two Quarterly 
                       Ended             Periods Ended 
                 ------------------   ------------------- 
(in millions,     March                March 
except per         29,    March 30,     29,    March 30, 
share amounts)    2025      2024       2025       2024 
---------------  -------  ---------   -------  ---------- 
 
Net sales           $824       $558    $1,526    $1,077 
 
Cost of goods 
 sold                736        488     1,367       965 
Selling, 
 general and 
 administrative       47         28        91        56 
Amortization of 
 intangibles          14         12        28        24 
Transaction and 
 other 
 activities           23          4        55        14 
Corporate 
 expense 
 allocation            -          5         3         9 
Operating 
 income (loss)         4         21      (18)         9 
Other expense 
 (income)              5          1        26       (1) 
Interest 
 expense              39          2        65         2 
---------------  -------  ---------   -------  -------- 
Income (loss) 
 before income 
 taxes              (40)         18     (109)         8 
Income tax 
 (benefit) 
 expense               1          4       (8)         2 
---------------  -------  ---------   -------  -------- 
Net income 
 (loss)            $(41)        $14    $(101)        $6 
---------------  -------  ---------   -------  -------- 
 
Basic and 
 diluted net 
 income per 
 share           $(1.15)      $0.44   $(2.85)     $0.19 
 
Outstanding 
weighted 
average shares 
Basic and 
 diluted            35.6       31.8      35.5      31.8 
 
 

Condensed Consolidated and Combined Statements of Cash Flows (Unaudited)

 
                                     Two Quarterly Periods Ended 
                               --------------------------------------- 
(in millions)                     March 29, 2025       March 30, 2024 
-----------------------------  ---------------------  ---------------- 
   Net cash from (used in) 
    operating activities                          $7            $(7) 
 
Cash flows from investing 
activities: 
Additions to property, plant, 
 and equipment, net                             (39)            (41) 
Cash acquired from GLT 
 acquisition                                      37               - 
Other investing activities                        22              28 
   Net cash from (used in) 
    investing activities                          20            (13) 
 
Cash flows from financing 
activities: 
Repayments on long-term 
 borrowings                                    1,556               - 
Proceeds from long-term 
 borrowings                                    (432)             (1) 
Transfers from Berry, net                         34               8 
Cash distribution to Berry                   (1,111)               - 
Debt fees and other, net                        (15)               - 
-----------------------------  ---------------------  -------------- 
   Net cash from financing 
    activities                                    32               7 
-----------------------------  ---------------------  -------------- 
Effect of currency 
 translation on cash                             (7)               2 
-----------------------------  ---------------------  -------------- 
Net change in cash and cash 
 equivalents                                      52            (11) 
Cash and cash equivalents at 
 beginning of period                             230             185 
-----------------------------  ---------------------  -------------- 
Cash and cash equivalents at 
 end of period                                  $282            $174 
-----------------------------  ---------------------  -------------- 
 

Condensed Consolidated Balance Sheets (Unaudited)

 
(in millions of 
USD)                     March 29, 2025              September 28, 2024 
----------------  ----------------------------  ---------------------------- 
Cash and cash 
 equivalents                             $ 282                         $ 230 
Accounts 
 receivable                                492                           359 
Inventories                                508                           259 
Other current 
 assets                                    146                            38 
Property, plant, 
 and equipment                           1,519                           949 
Goodwill, 
 intangible 
 assets, and 
 other long-term 
 assets                                  1,114                           972 
-----------------  ---------------------------  ---------------------------- 
Total assets                           $ 4,061                        $2,807 
-----------------  ---------------------------  ---------------------------- 
Current 
 liabilities, 
 excluding 
 current debt                              588                           457 
Current and 
 long-term debt                          1,998                             - 
Other long-term 
 liabilities                               382                           211 
Stockholders' 
 equity                                  1,093                         2,139 
-----------------  ---------------------------  ---------------------------- 
Total liabilities 
 and 
 stockholders' 
 equity                                $ 4,061                        $2,807 
-----------------  ---------------------------  ---------------------------- 
 
 

Reconciliation of Non-GAAP Measures and Estimates

(in millions of dollars)

 
Reconciliation of Net sales and Adjusted EBITDA on 
 a supplemental comparable basis by segment 
                  Quarterly Period ended March 
                            29, 2025            Quarterly Period ended March 30, 2024 
                  ----------------------------  ------------------------------------- 
                            Rest of                         Rest of 
                  Americas   World     Total    Americas     World         Total 
                  --------  -------  ---------  --------  -----------  -------------- 
Net sales          $ 473     $ 351       $ 824    $375       $183                $558 
Constant FX 
 rates                                             (15)      (11)                (26) 
GLT prior year                                    126         201                 327 
                                                --------  -----------  -------------- 
Comparable net 
 sales (1)(6)      $ 473     $ 351       $ 824    $486       $373                $859 
 
Operating Income    $ 8      $ (4)         $ 4    $20         $1                  $21 
Depreciation and 
 amortization        39        19           58      31        13                   44 
Transaction, 
 business 
 consolidation 
 and other 
 activities (2)       14        5           19     3           1                    4 
GAAP carve-out 
 allocation (3)       -         -            -      5           -                   5 
Other non-cash 
 charges (5)         3          5            8      -          2                    2 
----------------  --------  -------  ---------  --------  -----------  -------------- 
Adjusted EBITDA 
 (1)                $ 64     $ 25         $ 89    $59         $17                 $76 
Constant FX 
 rates                                             (2)        (1)                 (3) 
GLT prior year                                      10         14                  24 
----------------  --------  -------  ---------  --------  -----------  -------------- 
Comparable 
 Adjusted EBITDA 
 (1)(6)             $ 64     $ 25         $ 89    $67         $30                 $97 
----------------  --------  -------  ---------  --------  -----------  -------------- 
% vs. prior year 
 comparable          (4%)     (17%)       (8%) 
 
                  Two Quarterly Periods ended   Two Quarterly Periods ended March 30, 
                         March 29, 2025                         2024 
                  ----------------------------  ------------------------------------- 
                            Rest of                         Rest of 
                  Americas   World       Total  Americas     World              Total     LTM 
----------------  --------  -------  ---------  --------  -----------  --------------  ------ 
Net sales          $ 893     $ 633     $ 1,526    $723       $354              $1,077 
Constant FX 
 rates                                            (28)       (12)                (40) 
GLT prior year                                     202         336                538 
                                                --------  -----------  -------------- 
Comparable net 
 sales (1)(6)      $ 893     $ 633     $ 1,526    $897       $678              $1,575 
 
Operating Income    $ 1     $ (19)      $ (18)    $17        $(8)                  $9  $(168) 
Depreciation and 
 amortization         72       39          111      61         27                  88     197 
Transaction, 
 business 
 consolidation 
 and other 
 activities (2)       34       17           51      6          8                   14      68 
Impact from 
 hyperinflation      -         -             -     15               -              15       - 
Goodwill 
 impairment          -         -             -     -           -                    -     172 
GAAP carve-out 
 allocation (3)      2         1             3      8          1                    9      15 
Other non-cash 
 charges (4)(5)       11       15           26      3          4                    7      30 
----------------  --------  -------  ---------  --------  -----------  --------------  ------ 
Adjusted EBITDA 
 (1)               $ 120     $ 53        $ 173    $110        $32                $142    $312 
                                                                                       ------ 
Constant FX 
 rates                                            (6)          (1)                (7) 
GLT prior year                                      15        27                   41 
----------------  --------  -------  ---------  --------  -----------  --------------  ------ 
Comparable 
 Adjusted EBITDA 
 (1)(6)            $ 120     $ 53        $ 173    $119        $58                $177 
----------------  --------  -------  ---------  --------  -----------  --------------  ------ 
% vs. prior year 
 comparable           0%      (9%)        (2%) 
PF GLT Adjusted 
 EBITDA                                      8                                      8      59 
Synergies and 
 cost 
 reductions                                                                                65 
                                                --------  -----------  -------------- 
PF Adjusted 
 EBITDA                                                                                  $436 
 
 

Guidance

 
                                                  Fiscal 2025 
                  Fiscal 2025  Adjusted EBITDA      Midpoint 
Cash flow from 
 operating 
 activities         $60-$80    Adjusted EBITDA        $362 
Pre-merger cash 
 flow from 
 operating 
 activities (7)       90         GLT Pro forma         8 
                               ---------------  ---------------- 
                                     Full Year 
                                    Comparable 
Additions to PPE                      Adjusted 
 (net)               (75)               EBITDA        $370 
----------------  ----------- 
Post-merger 
 adjusted free 
 cash flow(1)      $75 - $95 
 
 

(1) Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States ("GAAP"). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. Management believes that Adjusted EBITDA and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of items that, in management's view, do not reflect our core operating performance. We define "Post-merger free cash flow" as cash flow from operating activities, less pre-merger free cash flow, less net additions to property, plant, and equipment. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company's liquidity. We believe post-merger free cash flow is also useful to an investor in evaluating our liquidity as it can assist in assessing a company's ability to fund its growth through its generation of cash and as pre-merger cash flow is not indicative of our current structure and operations.

We also use Adjusted EBITDA and comparable basis measures, among other measures, to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA is a measure widely used by investors, securities analysts, and other interested parties in our industry to measure a company's performance. We also believe these measures are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods.

(2) Includes restructuring, business optimization and other charges and YTD balance also includes $19 million of transaction compensation

(3) Consists of estimated parent-allocated charges for the period prior to merger which is required by GAAP as part of the carve-out financial statement process.

(4) Includes a $12 million inventory step-up charge related to GLT merger YTD and other non-cash charges.

(5) Includes stock compensation expense and equipment disposals

(6) The prior year comparable basis change excludes the impacts of foreign currency and acquisition/mergers.

(7) Pre-merger cash flow includes cash from operations prior to the merger and cash payments burdened by the transaction.

IR Contact Information

Robert Weilminster

EVP, Investor Relations

IR@magnera.com

(END) Dow Jones Newswires

May 07, 2025 05:30 ET (09:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10